CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
Hyun Gyung Lee, Eun Mi Yang, Chan Jong Kim
Ann Pediatr Endocrinol Metab. 2021;26(3):199-204.   Published online September 30, 2021
DOI: https://doi.org/10.6065/apem.2142046.023

Excel Download

Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
Annals of Pediatric Endocrinology & Metabolism. 2021;26(3):199-204   Crossref logo
Link1 Link2 Link3

Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism
Thyroid. 2015;25(1):43-50   Crossref logo
Link1 Link2

Adverse events related with propylthiouracil therapy of Graves’ Disease in children at Cipto Mangunkusumo Hospital Jakarta
International Journal of Pediatric Endocrinology. 2013;2013(S1):   Crossref logo
Link1 Link2 Link3

Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study
Clinical Endocrinology. 1998;49(4):451-457   Crossref logo
Link1 Link2 Link3

Neuroendocrine-Related Adverse Events Associated with Antidepressant Treatment in Children and Adolescents
CNS Neuroscience & Therapeutics. 2010;16(2):83-90   Crossref logo
Link1 Link2

Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease
Journal of the Endocrine Society. 2021;5(4):   Crossref logo
Link1 Link2

Immune-related and adverse events following low versus high initial dose of Viscum album L. in cancer patients
Annals of Oncology. 2016;27:vi515   Crossref logo
Link1 Link2 Link3

Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
Annals of Pediatric Endocrinology & Metabolism. 2016;21(2):70   Crossref logo
Link1

Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
Journal of Medical Case Reports. 2021;15(1):   Crossref logo
Link1 Link2 Link3

Methimazole-Induced Agranulocytosis in Patients with Graves' Disease Is More Frequent with an Initial Dose of 30 mg Daily than with 15 mg Daily
Thyroid. 2009;19(6):559-563   Crossref logo
Link1